Drug intelligence / Profile preview

Mepindolol

Development stage
Unknown
Modality
Small Molecules
Administration
Oral, Ophthalmic
01

Overview

Mepindolol is a small molecule beta blocker of the indole class, structurally described as a 2-methyl derivative of pindolol. It acts primarily as a selective beta1-adrenoreceptor antagonist with intrinsic sympathomimetic activity (ISA), meaning it can partially mimic the effects of catecholamines while blocking their action. This results in decreased heart rate and blood pressure, making it useful for managing cardiovascular conditions such as hypertension and angina pectoris. Additionally, mepindolol has been investigated for its ability to lower intraocular pressure in glaucoma by reducing aqueous humor production through antagonism of beta receptors in the ciliary body. The drug does not significantly affect lipid levels; total plasma cholesterol may decrease while HDL-cholesterol increases during therapy[1][4][6][7].

Other names
mepindolol sulfate
02

Targets

ADRB2 (β2)ADRB1 (β1)

Beyond the preview

Go deeper on Mepindolol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mepindolol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call